Monopar Therapeutics Inc. · NASDAQ:MNPR

Rioux Patrice sold 1 Monopar Therapeutics Inc. shares (Form 4)

Traded Aug 26, 2026 · Filed Aug 27, 2026

On Aug 26, 2026, Rioux Patrice (Acting Chief Medical Officer) sold 1 Monopar Therapeutics Inc. shares at US$111.26 for US$111 under a trading plan, leaving 5,065 shares. Filed Aug 27, 2026 (Form 4).

Sold
1 shares
Price
US$111.26
Value
US$111
Holding after
5,065 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Acting Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 26, 2026Common StockOption exercise1,380US$0.015,066Direct
Aug 26, 2026Common StockSale1US$111.265,065Direct

Source

View original at SEC

Related